Note: Taiga Biotechnologies's revenues are gauged from an analysis of company filings.
Taiga Biotechnologies's Income Statement (based on Industry Averages)
Taiga Biotechnologies P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Taiga Biotechnologies has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
August 16, 2022
20
35%
$40 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Taiga Biotechnologies is developing and marketing.
Taiga Biotechnologies doesn't have any recent trademark applications, indicating Taiga Biotechnologies is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
TAIGA Research and development in the biotechnology and pharmaceutical fields; testing, inspection, research, or development of biotechnology and pharmaceutical preparations for immunotherapies, cell-based therapeutics, and protein therapies
06/23/2020
EQUIVITA Veterinary medical apparatus for use in separating animal blood into components; veterinary medical apparatus for use in processing animal whole blood for the purpose of separating and stabilizing animal blood components; veterinary medical apparatus for use in processing animal whole blood for the purpose of separating animal blood components and parts and fittings therefor; veterinary medical apparatus, namely, syringe, tubing, valve, and assembly bag for use in processing animal whole blood for the purpose of separating and stabilizing animal blood components; veterinary medical apparatus, namely, syringe, tubing, valve and assembly bag for use in processing animal red blood cells with clinical medical reagents for the purpose of separating and stabilizing animal blood components; veterinary medical apparatus accessories, namely, syringes, tubing, valves, assembly bags, and clinical medical reagents for use in separating and stabilizing animal blood components
04/29/2019
EUNOVITA Veterinary medical apparatus for use in separating animal blood into components; veterinary medical apparatus for use in processing animal whole blood for the purpose of separating and stabilizing animal blood components; veterinary medical apparatus for use in processing animal whole blood for the purpose of separating animal blood components and parts and fittings therefor; veterinary medical apparatus, namely, syringe, tubing, valve, and assembly bag for use in processing animal whole blood for the purpose of separating and stabilizing animal blood components; veterinary medical apparatus, namely, syringe, tubing, valve and assembly bag for use in processing animal red blood cells with clinical medical reagents for the purpose of separating and stabilizing animal blood components; veterinary medical apparatus accessories, namely, syringes, tubing, valves, assembly bags, and clinical medical reagents for use in separating and stabilizing animal blood components
10/30/2018
See all trademarks and details in the Full Report.
Market Share of Taiga Biotechnologies's Largest Competitors
A competitive analysis shows these companies are in the same general field as Taiga Biotechnologies, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Taiga Biotechnologies.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Taiga Biotechnologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.